Feedback / Questions
pegtarazimod (RLS-0071) - ReAlta
https://www.businesswire.com/news/home/20250820235281/en/ReAlta-Life-Sciences-Receives-EMA-Orphan-Drug-Designation-for-RLS-0071-pegtarazimod-for-the-Treatment-of-Graft-Versus-Host-Disease
Aug 21, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next